Global Multiomics Services Market to Hit $3.56 Billion by 2030 at 20.1% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Multiomics Services Market Between 2026 And 2030?

The multiomics services market has experienced significant expansion in its size over recent years. Its valuation is projected to rise from $1.42 billion in 2025 to $1.71 billion in 2026, maintaining a compound annual growth rate (CAGR) of 20.4%. This historical growth can be attributed to factors such as increased genomics and proteomics research activities, the expansion of academic and clinical research funding, the growing availability of high-throughput sequencing technologies, an uptick in collaboration between research institutions, and advancements in bioinformatics tools.

The multiomics services market is projected to experience substantial growth over the coming years. This market is anticipated to reach $3.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.1%. This anticipated expansion during the forecast period stems from factors such as the increasing embrace of precision medicine approaches, escalating pharmaceutical investment in systems biology, the broadening scope of multiomics applications within drug discovery, the rising utilization of AI-based biological data interpretation, and the growing need for personalized therapeutic development. Key trends for this period encompass the increased adoption of integrated multiomics analysis platforms, a heightened demand for single-cell multiomics services, the expanding use of data-driven biological insights, the broadening of cloud-based omics data integration, and a sharpened focus on translational research applications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27355&type=smp

Which Primary Drivers Are Impacting The Multiomics Services Market Growth?

The expanding integration of personalized medicine is anticipated to fuel the expansion of the multiomics services market moving ahead. Personalized medicine is a healthcare approach utilizing an individual’s genetic and lifestyle data to customize treatments and medical care to their distinct requirements. This growing embrace of personalized medicine stems from individuals favoring health technologies providing real-time monitoring and treatment strategies uniquely adapted to their biological makeup. Multiomics services facilitate the progression of personalized medicine by combining various biological datasets, including genomics, transcriptomics, proteomics, and metabolomics, to offer a complete insight into an individual’s health status, thus enabling customized diagnosis, therapy, and preventive measures for diseases. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023, marking a considerable rise from the 12 approvals in 2022. Consequently, the rising acceptance of personalized medicine is propelling the development of the multiomics services market.

What Are The Main Segments Within The Multiomics Services Market Segment Structure?

The multiomics services market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Application: Biomarker Discovery, Drug Discovery And Development, Synthetic Biology, Other Applications

3) By End Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics Services, Single-Cell Transcriptomics Services, Single-Cell Proteomics Services, Single-Cell Epigenomics Services

2) By Bulk Multiomics: Genomics And Transcriptomics Integration Services, Genomics And Proteomics Integration Services, Transcriptomics And Proteomics Integration Services, Epigenomics And Transcriptomics Integration Services

Which Trends Are Shaping Growth In The Multiomics Services Market?

Leading companies in the multiomics services market are prioritizing the development of innovative methods, such as 3D genome mapping, to advance the understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping is defined as the process of determining the three-dimensional spatial arrangement of the genome within a cell’s nucleus. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology firm, introduced a suite of 3D multi-omics solutions aimed at accelerating and improving the precision of drug discovery. These solutions offer distinct capabilities like integrating genome-wide regulatory interaction data with multi-omics profiles in a single assay, thus providing comprehensive insights into gene regulation. Its proprietary Promoter Capture Hi-C technology enables precise mapping of long-range interactions between regulatory elements and target genes, including those in non-coding regions. The platform’s modular design, which includes GenLinkConnect, GenLinkResponse, and GenLinkProfile, supports SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Additionally, the GenLinkHub software offers an intuitive interface for 3D visualization, data management, and quality control, thereby enhancing researchers’ ability to interpret complex datasets and expedite drug discovery.

Who Are The Companies Participating In The Multiomics Services Market?

Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.

Get The Full Multiomics Services Market Report:

https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report

Where Is The Multiomics Services Market Most Concentrated Geographically?

North America was the largest region in the multiomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Multiomics Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/multiomics-services-global-market-report

Browse Through More Reports Similar to the Global Multiomics Services Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Bioinformatics Market Report

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Computational Biology Market Report

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795